Understand the source comparison
Purity Standards in the US vs China Peptides Comparison
Purity is the single most important variable for research use. Published data on peptide synthesis shows that the theoretical maximum HPLC purity achievable under rigorous preparative chromatography conditions is approximately 99.5%, with practical commercial
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Purity is the single most important variable for research use. Published data on peptide synthesis shows that the theoretical maximum HPLC purity achievable under rigorous preparative chromatography conditions is approximately 99.5%, with practical commercial ceilings of 99.0–99.3% for most peptides. The question in the US vs China peptides comparison is whether a given batch actually reaches that ceiling and whether the stated purity is independently verified.
- Research into peptide manufacturing quality, summarized on PubMed peptide manufacturing quality control literature, demonstrates that impurity profiles vary substantially between manufacturers even when stated purity values are similar. Two peptides both labeled “99% pure” can contain very different impurity spectra — one may have a single low-level truncation impurity, while another may have multiple deletion sequences and oxidized variants that together approach the 1% impurity limit.
- In the US vs China peptides comparison, this impurity spectrum question is where the largest practical differences appear. US-based third-party analytical labs operating under ISO 17025 accreditation apply consistent methodology across batches and manufacturers, making results comparable. The guide on how to read a peptide COA explains which specific elements of a purity certificate indicate rigorous versus superficial testing.